The Latest in Ankylosing spondylitis

Testing for latent tuberculosis infection

December 13, 2017

TNFi response evaluations may conflict when fibromyalgia, axial SpA coexist

December 8, 2017

Flare of nonradiographic axial SpA occurs often after adalimumab withdrawal for remission

December 7, 2017

Expert discusses risks of biosimilars in rheumatology

November 30, 2017

VIDEO: Beware of over-relying on MRI findings in axSpA

November 14, 2017

VIDEO: Obesity linked to worse outcomes in axial spondyloarthropathy

November 6, 2017

Biosimilars poised to save $54 billion over the next decade

October 25, 2017

Golimumab earns new FDA approvals

October 24, 2017

High ‘nocebo’ effect observed when patients knowingly switch to a biosimilar

October 18, 2017

Thoracic syndesmophytes common in ankylosing spondylitis

October 13, 2017

Launch of adalimumab biosimilar Amjevita postponed

September 29, 2017

Immunogenicity concerns for biosimilars so far don’t go beyond originator biologics

September 27, 2017

Early ankylosing spondylitis treatment stops transition from inflammatory to bone-forming fatty lesions

September 27, 2017

Ultrasound’s value for arthralgia may be to rule out IA

September 20, 2017

New recommendations tout biosimilars for rheumatologic diseases

September 7, 2017